NewsRoom Articles - Page 188 of 222

ThursdayJan 14, 2021 12:30 pm

Cooling Vests May Be Solution to PPE Discomfort for COVID-19 Healthcare Personnel

A team of scientists from the Radboud University Medical Center have tested out cooling vests that were initially designed for elite athletes on nursing staff who work long shifts in coronavirus wards wearing personal protective equipment (PPE). While PPE is essential, it can cause discomfort. The majority of the staff in the facility reported that they felt more comfortable with the vest on because it combats heat stress. The vest is now part of the center’s standard equipment. PPE’s are important as they help keep healthcare personnel, who are on the frontline of duty, safe during the coronavirus pandemic. However,…

WednesdayJan 13, 2021 2:30 pm

Scientists Trying to Eliminate Main Cause of Food Allergies

In the United States, 2% of grown-ups and nearly 7% of kids suffer from a food allergy. Annually, these allergies cost individuals time spent away from work or school and $25 billion in health care. In addition to this, some individuals develop serious complications from their allergies that may sometimes result in death. It’s important to discover ways to reduce the distress caused by food allergies. Companies that process food have already gone the extra mile to indicate ingredients on product labels to help people avoid items they may be allergic to. However, it may be possible to instead but…

WednesdayJan 13, 2021 12:15 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moving Forward with New Berubicin Clinical Trials, Determined to Help Address Unmet Needs of GBM Patients

IND approval from the FDA has given CNS Pharmaceuticals the green light needed to continue with clinical research of Berubicin in patients suffering from GBM and other brain/nervous system cancers Company holds the exclusive worldwide license for Berubicin, the first anthracycline to cross the blood-brain barrier in the adult brain The GBM therapeutics market is expected to increase to an estimated $3.3 billion in 2024 CNS Pharmaceuticals’ sublicensee will be conducting the first pediatric study using Berubicin CNS Pharmaceuticals (NASDAQ: CNSP) is a clinical-stage biotechnology company that is currently specializing in the development of novel treatments for primary and metastatic…

TuesdayJan 12, 2021 12:05 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Visualizes a World with Superior Bladder Cancer Surgical Procedures

Surgical imaging company Imagin Medical Inc. has developed a proprietary technology that enhances surgeons’ efforts to identify the full extent of bladder cancers and remove them Imagin’s i/Blue Imaging (TM) System uses blue light in combination with a fluorescent contrasting agent that highlights the tumor on an endoscope’s camera display to help surgeons remove the cancerous cells more completely than the white light standard Bladder cancer is the fourth most common cancer in men and the second most common genitourinary cancer The American Cancer Society forecasts that, during this year, about 81,400 new cases of bladder cancer would be reported…

TuesdayJan 12, 2021 10:45 am

Study Discovers That Avocados Boost Gut Microbiota

A recent study from the University of Illinois shows that consuming avocados daily can improve gut health. While it is common knowledge that avocados are high in monounsaturated fat and dietary fiber, it was unclear how they affected the microbes found in the gut. The lead author of the paper, Sharon Thompson, stated that while researchers knew that eating avocados decreases blood cholesterol concentration, their influence on the metabolites produced by the microbes in the gut and their influence on the microbes themselves remained unclear. The researchers discovered that individuals who consumed avocado daily as part of a meal had…

MondayJan 11, 2021 1:00 pm

Research Discovers That Teens Are Dieting Because of Weight Worries

A study conducted by researchers from University College London has discovered that in the United Kingdom considerably higher numbers of young men and young women from Generation Z were not only overestimating their weight but also trying to lose weight through dieting. Data shows that approximately 30% of 14-year old boys and girls were trying to lose weight in 2005. This number grew to 42% in 2015, which raises some concerns. The research discovered that girls who were trying to lose weight would likely experience depressive symptoms. Dr. Francesca Solmi, the lead author of the study, stated that the team’s…

FridayJan 08, 2021 10:45 am

Researchers Discover Why Lungs Are Severely Affected by Virus-Related Attacks

A new study conducted by researchers from Sweden’s Karolinska Institutet describes how macrophages, which are different kinds of immune cells, can develop in the lungs and cause serious lung diseases. Macrophages have many functions in the body, including protecting the lungs from attacks by bacteria and viruses. The lungs’ structure exposes them to both these pathogens through blood and air. However, under specific conditions, the macrophages can also cause severe lung disease such as the coronavirus and COPD (chronic obstructive pulmonary disease). However, research on human lung macrophages development is scanty. Macrophages develop from a type of white blood cell…

FridayJan 08, 2021 10:04 am

Brain Scientific Inc. (BRSF) One of Ten Companies Featured in Global Brain Diagnostics Devices Industry Report

Market expected to progress at CAGR of 9% until 2024, driven by technological advances and the integration of software and analytical tools in brain monitoring devices. North American market continues to dominate. As a company revolutionizing brain diagnostic devices market, BRSF seems ideally positioned within thriving market. A recently published report on EEG and EMG devices market shows that the global brain monitoring market is expected to progress at a CAGR of 9%, increasing by more than $740 million from 2019 to 2024 (https://ibn.fm/qinVW). The report highlights that the market is fragmented with several players occupying the market share; the…

WednesdayJan 06, 2021 12:00 pm

Dual-Acting Antibiotics Offer Hope Against Superbugs

Researchers from Wistar Institute have found a new category of compounds that merge the killing of bacterial pathogens that are drug resistant through the use of antibiotics, with a swift immune response used to fight antimicrobial resistance. Last year, the WHO declared antimicrobial resistance (AMR) as a top public health threat. Estimates show that by the year 2050, infections that are antibiotic resistant could not only thrust upon the world economy a collective burden of $100 trillion but also claim the lives of nearly 10 million people every year. It does not help that the number of bacteria growing treatment…

WednesdayJan 06, 2021 11:49 am

Brain Scientific Inc. (BRSF) Disrupts Expensive EEG Market

70% of those with epilepsy could live seizure-free lives if properly diagnosed, treated Machine-learning algorithms using EEG signals have potential to accurately predict epileptic seizures, allowing patient to take preventive measures NeuroCap provides cost-effective solution that is disrupting EEG market Brain Scientific (OTCQB: BRSF) is modernizing brain diagnostics with cutting-edge technology that bridges the widening gap in access to quality care. The use of artificial intelligence (“AI”) and machine learning (“ML”) is at the forefront of improving epileptic patients’ access to neurological care. According to the World Health Organization (“WHO”), 50 million people worldwide have epilepsy (https://ibn.fm/NUPCJ). Approximately 70% of those…